Nonclinical Efficacy Testing » Non-Clinical CROs and Agencies » Accutest Research Laboratories

Accutest Research Laboratories

Accutest Research Laboratories is a CRO based in India that offers a wide range of development support, from preclinical to clinical trials. They can also conduct preclinical studies in their own facilities, with their integrated service system, including analysis and regulatory compliance, being a key strength. This article introduces the features of Accutest Research Laboratories' preclinical studies.

Features of Accutest Research Laboratories' Contract Non-Clinical Testing Services

Advanced testing techniques, including MoA analysis

Our strengths lie in advanced testing techniques that support Mechanism of Action (MoA) analysis. While general non-clinical studies often focus on superficial evaluations like efficacy and toxicity, our company offersAnalysis is possible to clarify which molecular pathways or physiological mechanisms candidate compounds act on.In the early stages of drug discovery, we support target validation and the acquisition of scientific evidence to support drug efficacy. Furthermore, our ability to elucidate complex mechanisms of action, which is crucial for the development of biologics and advanced pharmaceuticals, contributes to reducing development risks and facilitating a smooth transition to subsequent studies.

High reliability through GLP/GCLP and international regulatory compliance

Operational structure compliant with GLP (Good Laboratory Practice) and GCLP (Good Clinical Laboratory Practice)and is strong in ensuring data reliability and reproducibility. These standards demand strict quality control from test planning, execution, recording, and reporting, ensuring the eligibility of the submission documents to regulatory authorities. They also comply with the standards of major international regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency, and the World Health Organization, and have successfully passed numerous inspections. The non-clinical data acquired can be directly utilized for global development and approval applications.

Powerful bioanalytical platform centered on LC-MS/MS

We have an advanced bioanalysis platform centered on LC-MS/MS (Liquid Chromatography-Mass Spectrometry), excelling in precise quantitative analysis for non-clinical studies.Utilizing a large number of LC-MS/MS instrumentsThis enables highly sensitive and selective measurements, allowing for the understanding of the pharmacokinetics of trace amounts of drugs and metabolites. Another feature is our extensive portfolio of validated analytical methods, ensuring rapid assay setup and highly reproducible data acquisition. We can accommodate not only small molecule drugs but also biopharmaceuticals and immunogenicity testing, offering flexibility to meet the increasingly complex needs of drug development. We have established a system capable of providing reliable bioanalysis essential for bridging non-clinical to clinical stages.

Integrated support from non-clinical to clinical and regulatory submission

Accutest Research Laboratories' strengths are,An integrated CRO that can provide consistent support from preclinical studies to clinical trials and regulatory submission. maintain a system that bridges preclinical efficacy, safety, and pharmacokinetic data to subsequent clinical trial designs, contributing to overall development efficiency. We also have experience in dealing with regulatory authorities such as the U.S. Food and Drug Administration and the European Medicines Agency, allowing us to establish strategies with an eye toward regulatory submission from the trial planning stage. By ensuring data integrity and regulatory compliance between each phase, we reduce development risks and accelerate the time to approval. Our comprehensive support, which goes beyond mere contract research, is a key advantage.

An example of a disease model held by Accutest Research Laboratories

The pathological models I possess are not listed on the official website.

Accutest Research Laboratories Non-clinical Study Cases

Information on non-clinical study examples was not available on the official website.

Accutest Research Laboratories Company Information

Address A-77, Thane - Belapur Rd, TTC Industrial Area, MIDC Industrial Area, Kopar Khairane, Mumbai, Maharashtra 400709, India
Tel +91-22 2778 0720
Website https://www.accutestglobal.com/

3 Recommended Contract Research Organizations
for Non-Clinical Studies
— by Target goal and Expertise

In non-clinical development, the choice of contract research organization shapes the quality of the data and the time it takes to reach the next decision. Below, three CROs are introduced by the type of study they support: pharmacology (efficacy) studies, safety studies, and pharmacokinetic (PK/PD) studies. Each summary describes the services the company offers so that you can match a provider to your target and development objective.

Pharmacology (Efficacy) StudiesDisease-Relevant Models for
Translational Drug Evaluation
SMC Laboratories, Inc.
Reference: SMC Laboratories, Inc. official website (https://www.smccro-lab.com/)

SMC Laboratories, Inc.

SMC Laboratories is a specialized non-clinical CRO focused on in vivo pharmacology and efficacy studies using disease-relevant animal models, particularly in fibrosis, inflammation, metabolic diseases, and oncology.

Areas of Expertise
Disease-Relevant Model Portfolio

SMC Laboratories offers models covering the liver, lung, kidney, intestine, and oncology. Its portfolio includes the proprietary STAM™ model for MASH, fibrosis, and hepatocellular carcinoma.

Study Design Based on Target Biology

Study plans are developed around the target biology, mechanism of action, disease stage, and development objective. Pharmacological endpoints can be combined with histopathology, biomarkers, and disease-specific readouts.

Support from Target Validation to Proof of Concept

With experience from more than 1,000 studies for clients in 30 countries, SMC Laboratories supports programs from target validation and candidate selection through in vivo proof-of-concept studies.

Safety StudiesComprehensive Safety Assessment for
Preclinical Development
Charles River Laboratories
Reference: Charles River Laboratories official website (https://www.criver.com/)

Charles River Laboratories

Charles River provides non-clinical toxicology and safety assessment services for programs ranging from exploratory safety studies to IND-enabling development.

Areas of Expertise
General Toxicology Across Study Designs

Services include single- and repeat-dose toxicology, dose-range finding, and general toxicology studies across multiple species and administration routes.

Non-GLP and GLP Study Support

Charles River supports both non-GLP and GLP studies, allowing sponsors to progress from early safety characterization to studies intended for regulatory submissions.

Integrated IND-Enabling Safety Assessment

Toxicology studies can be integrated with toxicokinetics, clinical pathology, histopathology, and safety pharmacology to support interpretation and IND-enabling safety packages.

Pharmacokinetic (PK/PD) StudiesConnecting Drug Exposure with
Pharmacological Response
Inotiv
Reference: Inotiv official website (https://www.inotiv.com/)

Inotiv

Inotiv provides integrated PK/PD, DMPK, and bioanalytical services to characterize drug exposure and its relationship with pharmacological response.

Areas of Expertise
Pharmacokinetic Characterization

PK studies characterize exposure, half-life, clearance, and other pharmacokinetic parameters needed to understand how a candidate behaves in the selected model.

Exposure–Response Evaluation

Pharmacokinetic data can be combined with pharmacodynamic endpoints and bioanalysis to evaluate the relationship between drug exposure and pharmacological response.

Integrated DMPK and Development Support

Integrated DMPK, pharmacology, and safety information supports candidate comparison, dose selection, dosing-frequency optimization, and decisions about subsequent preclinical development.

By Therapeutic Area
Disease Animal Models
and Reviews
Proven Capability, Expertise and Track Record
Top 3 Non-Clinical CRO Services